The WEDI MPA process is designed to solicit WEDI member input on topical issues, public and private sector proposals, government regulations, or requests for information (RFI). The process is designed to advise the WEDI Board of Directors as it develops the official WEDI response.
For more information on the proposed rule, please refer to this link- https://www.cms.gov/newsroom/fact-sheets/2026-cms-interoperability-standards-prior-authorization-drugs-proposed-rule
The Centers for Medicare & Medicaid Services (CMS) has released the 2026 CMS Interoperability Standards and Prior Authorization for Drugs proposed rule (CMS 0062 P), advancing its ongoing effort to streamline and modernize electronic prior authorization. The proposal is intended to provide patients and providers with a faster, more transparent, and more reliable prior authorization process. It builds on earlier CMS actions, including the 2020 CMS Interoperability and Patient Access final rule (CMS 9115 F) and the 2024 CMS Interoperability and Prior Authorization final rule (CMS 0057 F), which together established a framework for interoperability APIs across multiple public and private health coverage programs.
This WEDI MPA event is exclusive to WEDI members. To learn about WEDI member benefits, please contact Bill Allder at ballder@wedi.org
Exclusive to WEDI Members
Have a login? Login Now
{{vm.loginInfo.errorMessage}}
Create an Account
Forgot your Username or Password?
Register as Guest
Address
Phone
{{slot.Name}}
{{ vm.EventInfo.EventSettings.NoShowPolicy }}